Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

‘Sustaining masculinity’: a scoping review of anabolic androgenic steroid use by older males
Evelyn Hearne, Amanda Atkinson, Ian D. Boardley, et al.
Drugs Education Prevention and Policy (2022) Vol. 31, Iss. 1, pp. 27-53
Open Access | Times Cited: 10

Showing 10 citing articles:

The world's first anabolic‐androgenic steroid testing trial: A two‐phase pilot combining chemical analysis, results dissemination and community feedback
Timothy Piatkowski, Ross Coomber, Cameron Francis, et al.
Addiction (2025)
Open Access | Times Cited: 3
“I would never go to the doctor and speak about steroids”: Anabolic androgenic steroids, stigma and harm
Luke Cox, Timothy Piatkowski, Jim McVeigh
Drugs Education Prevention and Policy (2024), pp. 1-13
Open Access | Times Cited: 14
Big business: The private sector market for image and performance enhancing drug harm reduction in the UK
Luke A. Turnock, Nick Gibbs, Luke Cox, et al.
International Journal of Drug Policy (2023) Vol. 122, pp. 104254-104254
Open Access | Times Cited: 18
Androgen abuse: Risks and adverse effects in men
Bonnie Grant, Elizabeth Hyams, Rhianna Davies, et al.
Annals of the New York Academy of Sciences (2024) Vol. 1538, Iss. 1, pp. 56-70
Open Access | Times Cited: 7
What is the prevalence of anabolic‐androgenic steroid use among women? A systematic review
Timothy Piatkowski, Bianca Whiteside, Jonathan Robertson, et al.
Addiction (2024) Vol. 119, Iss. 12, pp. 2088-2100
Open Access | Times Cited: 7
The Association Between the Nonmedical use of Anabolic–Androgenic Steroids and Interpersonal Violence: A Meta-Analysis
Katinka van de Ven, John M. Malouff, Jim McVeigh
Trauma Violence & Abuse (2023) Vol. 25, Iss. 2, pp. 1484-1495
Open Access | Times Cited: 11
Community pharmacy’s role in dispensing androgens and supporting harm reduction amid current policy dilemmas
Timothy Piatkowski, Lkhagvadulam Ayurzana, Michelle A. King, et al.
Substance Abuse Treatment Prevention and Policy (2025) Vol. 20, Iss. 1
Open Access
Feasibility of implementing current best clinical practice for people who are using anabolic androgenic steroids within a Swiss primary care practice: a quality assurance study
Raphael Magnolini, Kuvinda Kossinna, Daniel Bjasch, et al.
Schweizerische medizinische Wochenschrift (2025) Vol. 155, Iss. 2, pp. 4225-4225
Open Access
Novel wellbeing and repair peptide use in the UK: Netnographic findings
Luke A. Turnock, Evelyn Hearne
Performance Enhancement & Health (2024), pp. 100293-100293
Open Access | Times Cited: 2
Managing risks and harms associated with the use of anabolic steroids: a qualitative study
Julio Mario Xerfan do Amaral, Andreas Kimergård, Paolo Deluca
Research Square (Research Square) (2024)
Open Access
Page 1

Scroll to top